Skip to content
Find a Provider
Walter Richard Burack, M.D., Ph.D.

Walter Richard Burack, M.D., Ph.D.

UR Medicine Labs

No ratings currently available, see text in Ratings section below for explanation.

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

Contact

Office (585) 275-5662
Fax (585) 276-2390
Administrative (585) 275-1959

About Me

Dr. Burack is the Vice Chair for Clinical Operations in the Department of Pathology and Laboratory Medicine. Prior to this role, he was director of Hematopathology, which includes the Flow Cytometry Laboratory, tissue banking activities, and the Hematopathology Fellowship Program. This division work...
Dr. Burack is the Vice Chair for Clinical Operations in the Department of Pathology and Laboratory Medicine. Prior to this role, he was director of Hematopathology, which includes the Flow Cytometry Laboratory, tissue banking activities, and the Hematopathology Fellowship Program. This division works closely with Wilmot Cancer Institute and Pediatric Oncology to evaluate and diagnose lymphomas, leukemias, and related disorders.

Certified Specialties

Hematopathology - American Board of Pathology

Pathology, Clinical Pathology/Laboratory Medicine - American Board of Pathology

Faculty Appointments

Professor - Department of Pathology and Laboratory Medicine (SMD)

Professor - Cancer Center - Joint

Credentials

Residency & Fellowship

Fellowship, Hematopathology, Barnes Jewish Hospital. 1998 - 1999

Residency, Pathology - Clinical, University of Virginia Hospitals. 1995 - 1998

Education

MD | University of Virginia School of Medicine. 1995

Awards

2018 Chairman's Recognition Award. 2018

Eric A. Schenk Award for Excellence in Teaching. 2014

Excellence in 2nd Year Teaching. 2010

Class of 2010 Professor of the Year. 2007

Class of 2009 Professor of the Year. 2006

Class of 2008 Lecturer of the Year. 2005

Class of 2006 Distinguished Teacher Award. 2004

Research

Dr. Burack's research interests include the molecular mechanisms of lymphoma progression and development of molecular methods to refine diagnostics, particularly of lymphomas and leukemias. He recently became co-investigator on a grant to study the role of immune-senescence in lymphomagenesis, the r...
Dr. Burack's research interests include the molecular mechanisms of lymphoma progression and development of molecular methods to refine diagnostics, particularly of lymphomas and leukemias. He recently became co-investigator on a grant to study the role of immune-senescence in lymphomagenesis, the role of immune microenvironment in determining response to therapy, and the role of immune function in the symptoms of lymphoma via analysis of rare immune cell populations by advanced flow cytometry.

Research Lab

Clinical Trials

ULAB-03012~Tissue Procurement Facility Collection of specimens and epidemiological and clinical outcomes data in patients with hematological malignancies 

Lead Researcher: Walter Richard Burack

This research is being done because we hope that a better understanding of hematologic malignancies will allow us to develop new and better treatments.

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

Lead Researcher: Walter Richard Burack

The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (includin...

Publications

Journal Articles

Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium.

Day JR, Larson MC, Durani U, Koff JL, Wang Y, Habermann TM, Lossos IS, Nastoupil LJ, Strouse CS, Chihara D, Martin P, Leonard JP, Cohen JB, Kahl BS, Ruan J, Burack R, Friedberg JW, Cerhan JR, Flowers CR, Link BL, Maurer MJ, Casulo C

Blood advances.. 2024 November 27 Epub 11/27/2024.

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis.

Abro B, Maurer MJ, Habermann TM, Burack R, Chapman JR, Cohen JB, Friedberg JW, Inghirami GG, Kahl BS, Larson MC, Link BL, Lossos IS, Martin P, McDonnell T, Nastoupil LJ, Riska S, Syrbu SI, Vega F, Vij K, Flowers CR, Cerhan JR, Jaye DL, Feldman AL

Blood.. 2024 September 10 Epub 09/10/2024.

T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features.

El Hussein S, Fang H, Jelloul FZ, Wang W, Loghavi S, Miranda RN, Friedberg JW, Burack WR, Evans AG, Xu J, Medeiros LJ

Archives of pathology & laboratory medicine.. 2024 August 1148 (8):914-920. Epub 1900 01 01.

Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.

Maurer MJ, Casulo C, Larson MC, Habermann TM, Lossos IS, Wang Y, Nastoupil LJ, Strouse C, Chihara D, Martin P, Cohen JB, Kahl BS, Burack WR, Koff JL, Mun Y, Masaquel A, Wu M, Wei MC, Shewade A, Li J, Cerhan JR, Link BK, Flowers CR

Haematologica.. 2024 July 1109 (7):2177-2185. Epub 07/01/2024.

Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?

George GV, Aldowitz DG, Jajosky AN, Wallace DS, Burack WR, Friedberg JW, El Hussein S

EJHaem.. 2024 June 5 (3):599-602. Epub 04/24/2024.

ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.

George GV, Wallace DS, Wang Y, Carney J, Elsadawi M, Burack WR, Evans AG, Barr PM, Velez MJ, El Hussein S

Histopathology.. 2024 April 84 (5):900-902. Epub 11/30/2023.

Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment.

Yeo YY, Qiu H, Bai Y, Zhu B, Chang Y, Yeung J, Michel HA, Wright K, Shaban M, Sadigh S, Nkosi D, Shanmugam V, Rock P, Tung Yiu SP, Cramer P, Paczkowska J, Stephan P, Liao G, Huang AY, Wang H, Chen H, Frauenfeld L, Mitra B, Gewurz BE, Schürch CM, Zhao B, Nolan GP, Zhang B, Shalek AK, Angelo M, Mahmood F, Ma Q, Burack WR, Shipp MA, Rodig SJ, Jiang S

bioRxiv : the preprint server for biology.. 2024 March 7 Epub 03/07/2024.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

Cerhan JR, Maurer MJ, Link BK, Feldman AL, Habermann TM, Jaye DL, Burack WR, McDonnell TJ, Vega F, Chapman JR, Syrbu S, Vij KR, Inghirami G, Leonard JP, Bernal-Mizrachi L, Farooq U, Witzig TE, Weiner GJ, Wang Y, Alderuccio JP, Slager SL, Larson MC, Riska SM, Gysbers BJ, Lunde JJ, Reicks TW, Ayers AA, O'Leary CB, Yost KJ, Liu H, Nowakowski GS, Ruan J, Chihara D, Koff JL, Casulo C, Thompson CA, Cohen JB, Kahl BS, Nastoupil LJ, Lossos IS, Friedberg JW, Martin P, Flowers CR

American journal of hematology.. 2024 March 99 (3):408-421. Epub 01/13/2024.

Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.

Zhou T, Curry CV, Khanlari M, Shi M, Cui W, Peker D, Chen W, Wang E, Gao J, Shen Q, Xie W, Jelloul FZ, King RL, Yuan J, Wang X, Zhao C, Obiorah IE, Courville EL, Nomura E, Cherian S, Xu ML, Burack WR, Liu HX, Jabbour EJ, Takahashi K, Wang W, Wang SA, Khoury JD, Medeiros LJ, Hu S

Blood cancer journal.. 2024 January 2514 (1):19. Epub 01/25/2024.

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.

Burack WR, Li H, Adlowitz DG, Spence JM, Rimsza LM, Shadman M, Spier C, Kaminski MS, Leonard JP, Leblanc M, Smith SM, Friedberg JW

Blood advances.. 2023 September 127 (17):5082-5090. Epub 1900 01 01.

The Complete Blood Count: Increasing Its Precision and Impact.

Burack WR, Lichtman MA

Annals of internal medicine.. 2023 August 176 (8):eL230165. Epub 1900 01 01.

The role of splenectomy in management of splenic B-cell lymphomas.

Archibald WJ, Baran AM, Williams AM, Salloum RM, Richard Burack W, Evans AG, Syposs CR, Zent CS

Leukemia research.. 2023 May 128 :107053. Epub 03/02/2023.

Web Exclusive. Annals On Call - The Complete Blood Count: Cleaning Up the Clutter.

Centor RM, Burack WR, Lichtman MA

Annals of internal medicine.. 2023 April 176 (4):eA220007. Epub 04/04/2023.

Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.

El Hussein S, Wang X, Fang H, Jelloul FZ, Wang W, Loghavi S, Vega F, Miranda RN, Muzzafar T, Manning JT, Khoury JD, Burack WR, Evans AG, Medeiros LJ

The American journal of surgical pathology.. 2022 September 146 (9):1291-1297. Epub 05/16/2022.

Hypergammaglobulinemia as a presenting feature of Mantle cell lymphoma.

Liu L, Adlowitz DG, Rock P, Casulo C, Burack WR

Leukemia & lymphoma.. 2022 August 63 (8):2005-2008. Epub 03/31/2022.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.

El Hussein S, Yabe M, Wang W, Pemmaraju N, Loghavi S, Jelloul FZ, Fang H, Medeiros LJ, Burack WR, Evans AG, Liesveld JL, Bennett JM

EJHaem.. 2022 August 3 (3):954-957. Epub 07/03/2022.

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.

Casulo C, Larson MC, Lunde JJ, Habermann TM, Lossos IS, Wang Y, Nastoupil LJ, Strouse C, Chihara D, Martin P, Cohen JB, Kahl BS, Burack WR, Koff JL, Mun Y, Masaquel A, Wu M, Wei MC, Shewade A, Li J, Cerhan J, Flowers CR, Link BK, Maurer MJ

The Lancet. Haematology.. 2022 April 9 (4):e289-e300. Epub 1900 01 01.

An Unusual Case of Multiple Myeloma with Light-Chain Cast Nephropathy Secondary to a Very Large Plasmacytoma without Bone Marrow Involvement.

Komisarof J, Lipof J, DiTursi J, Chowdhry A, Grace Choung HY, Burack WR, Constine L, Passero F

Case reports in hematology.. 2022 2022 :7531142. Epub 02/21/2022.

A Young Boy With Hemophagocytic Lymphohistiocytosis Presenting With Vaccine-Related Granulomatous Dermatitis: A Case Report and Literature Review.

Zengin HB, Reyes-Barron C, Cusick E, Cordisco M, Katzman PJ, Burack WR, Scott G

The American Journal of dermatopathology.. 2021 December 143 (12):e267-e272. Epub 1900 01 01.

Fc?RI and Fc?RIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia.

Norris PAA, Segel GB, Burack WR, Sachs UJ, Lissenberg-Thunnissen SN, Vidarsson G, Bayat B, Cserti-Gazdewich CM, Callum J, Lin Y, Branch D, Kapur R, Semple JW, Lazarus AH

Haematologica.. 2021 January 1106 (1):250-254. Epub 01/01/2021.

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity

Valle-Argos B, Chiodin G, Bryant DJ, Taylor J, Lemm E, Duriez PJ, Rock PJ, Strefford JC, Forconi F, Burack RW, Packham G, Stevenson FK.

Sci Rep. 2021; 11(1): 11676.

Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target

Palacios F, Yan XJ, Ferrer G, Chen SS, Vergani S, Yang X, Gardner J, Barrientos JC, Rock P, Burack R, Kolitz JE, Allen SL, Kharas MG, Abdel-Wahab O, Rai KR, Chiorazzi N.

Leukemia. 2021; 35(4): 1037-52.

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Chiodin G, Allen JD, Bryant D, Rock P, Martino EA, Valle-Argos B, Duriez PJ, Watanabe Y, Henderson I, Blachly JS, McCann KJ, Strefford JC, Packham G, Geijtenbeek TB, Figdor C, Wright G, Staudt LM, Burack R, Bowden T, Crispin M, Stevenson FK, Forconi F.

Blood. 2021; .

Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).

Meacham PJ, Williams AM, Strawderman M, Baran AM, Archibald WJ, Wallace DS, Tschernia NP, Burack WR, Barr PM, Zent CS

Leukemia & lymphoma.. 2020 July 61 (7):1636-1644. Epub 03/16/2020.

Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.

Fries C, Adlowitz DG, Spence JM, Spence JP, Rock PJ, Burack WR

Pediatric blood & cancer.. 2020 June 67 (6):e28280. Epub 04/11/2020.

A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia.

Fries C, Burack WR

Leukemia research.. 2018 December 75 :15-22. Epub 11/03/2018.

Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia.

Hudson CA, Burack WR, Bennett JM

Leukemia research.. 2018 October 73 :12-15. Epub 08/28/2018.

Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.

Hudson CA, Burack WR, Leary PC, Bennett JM

American journal of clinical pathology.. 2018 August 30150 (4):293-302. Epub 1900 01 01.

Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells.

Aslam R, Burack WR, Segel GB, McVey M, Spence SA, Semple JW

British journal of haematology.. 2018 April 181 (2):262-264. Epub 02/06/2017.

R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study.

Barr PM, Li H, Burack WR, LeBlanc M, Smith SM, Gopal AK, Floyd JD, Persky DO, Press OW, Fisher RI, Friedberg JW

The Lancet. Haematology.. 2018 March 5 (3):e102-e108. Epub 01/26/2018.

Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment.

Burack WR, Spence JM, Spence JP, Spence SA, Rock PJ, Shenoy GN, Shultz LD, Bankert RB, Bernstein SH

Blood advances.. 2017 July 111 (16):1263-1273. Epub 07/07/2017.

Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.

Hunter BD, Herr M, Meacham PJ, Barlaskar F, Evans AG, Burack WR, Liesveld JL, Becker MW, Milner LA, Constine LS, Dhakal S, Barr PM, Friedberg JW, Casulo C

Clinical lymphoma, myeloma & leukemia.. 2017 March 17 (3):145-151. Epub 11/23/2016.

Green Inclusions in Neutrophils and Monocytes Are an Indicator of Acute Liver Injury and High Mortality.

Patel N, Hoffman CM, Goldman BI, Bentley K, Burack WR, Evans AG

Acta haematologica.. 2017 138 (2):85-90. Epub 08/17/2017.

Next-Generation Sequencing for Minimal Residual Disease Surveillance in Acute Lymphoblastic Leukemia: An Update.

Reyes-Barron C, Burack WR, Rothberg PG, Ding Y

Critical reviews in oncogenesis.. 2017 22 (5-6):559-567. Epub 1900 01 01.

Prognostic Impact of Cell of Origin in Limited-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP With or Without Radiation Therapy.

Youn P, Cummings MA, Dhakal S, Burack WR, Casulo C, Barr PM, Friedberg JW, Constine LS

International journal of radiation oncology, biology, physics.. 2016 October 196 (2S):E495. Epub 1900 01 01.

Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.

Evans AG, Ahmad A, Burack WR, Iqbal MA

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2016 October 29 (10):1183-99. Epub 07/08/2016.

Langerhans Cell Histiocytosis Shows Distinct Cytoplasmic Expression of Major Histocompatibility Class II Antigens.

Redd L, Schmelz M, Burack WR, Cook JR, Day AW, Rimsza L

Journal of hematopathology.. 2016 September 9 (3):107-112. Epub 03/10/2016.

Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes.

Kuzin II, Kates SL, Ju Y, Zhang L, Rahimi H, Wojciechowski W, Bernstein SH, Burack R, Schwarz EM, Bottaro A

European journal of immunology.. 2016 July 46 (7):1752-7. Epub 05/06/2016.

Splenic lymphocyte subtypes in immune thrombocytopenia: increased presence of a subtype of B-regulatory cells.

Aslam R, Segel GB, Burack R, Spence SA, Speck ER, Guo L, Semple JW

British journal of haematology.. 2016 April 173 (1):159-60. Epub 06/24/2015.

Real-time analysis of the detailed sequence of cellular events in mAb-mediated complement-dependent cytotoxicity of B-cell lines and of chronic lymphocytic leukemia B-cells.

Lindorfer MA, Cook EM, Tupitza JC, Zent CS, Burack R, de Jong RN, Beurskens FJ, Schuurman J, Parren PW, Taylor RP

Molecular immunology.. 2016 February 70 :13-23. Epub 12/12/2015.

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.

Till BG, Li H, Bernstein SH, Fisher RI, Burack WR, Rimsza LM, Floyd JD, DaSilva MA, Moore DF, Pozdnyakova O, Smith SM, LeBlanc M, Friedberg JW

British journal of haematology.. 2016 January 172 (2):208-18. Epub 10/22/2015.

Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node.

Nedelkovska H, Rosenberg AF, Hilchey SP, Hyrien O, Burack WR, Quataert SA, Baker CM, Azadniv M, Welle SL, Ansell SM, Kim M, Bernstein SH

PloS one.. 2016 11 (5):e0155347. Epub 05/26/2016.

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.

Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL

British journal of haematology.. 2015 October 171 (2):205-209. Epub 06/18/2015.

Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Halliley JL, Tipton CM, Liesveld J, Rosenberg AF, Darce J, Gregoretti IV, Popova L, Kaminiski D, Fucile CF, Albizua I, Kyu S, Chiang KY, Bradley KT, Burack R, Slifka M, Hammarlund E, Wu H, Zhao L, Walsh EE, Falsey AR, Randall TD, Cheung WC, Sanz I, Lee FE

Immunity.. 2015 July 2143 (1):132-45. Epub 07/14/2015.

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.

Pulvino M, Chen L, Oleksyn D, Li J, Compitello G, Rossi R, Spence S, Balakrishnan V, Jordan C, Poligone B, Casulo C, Burack R, Shapiro JL, Bernstein S, Friedberg JW, Deshaies RJ, Land H, Zhao J

Oncotarget.. 2015 June 206 (17):14796-813. Epub 1900 01 01.

Immunohistochemical expression of mTOR in germinal center and nongerminal center group of diffuse large B-cell lymphoma: a clinicopathological study.

Vajpayee N, Burack R, Wang D, Hutchison RE, Gajra A

Clinical lymphoma, myeloma & leukemia.. 2015 March 15 (3):159-63. Epub 10/02/2014.

Systematic review of the effectiveness of fine-needle aspiration and/or core needle biopsy for subclassifying lymphoma.

Frederiksen JK, Sharma M, Casulo C, Burack WR

Archives of pathology & laboratory medicine.. 2015 February 139 (2):245-51. Epub 1900 01 01.

Transformed follicular non-Hodgkin lymphoma.

Casulo C, Burack WR, Friedberg JW

Blood.. 2015 January 1125 (1):40-7. Epub 12/11/2014.

Using Flow Cytometry for the Diagnosis of Lung Neuroendocrine Carcinoma With Samples From Endobronchial Ultrasound Fine Needle Aspiration and Pleural Fluid

Journal of Interdisciplinary Histopathology. 2015; 3(1): 3-8.

Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutation.

Spence JM, Spence JP, Abumoussa A, Burack WR

Genome medicine.. 2015 7 (1):24. Epub 03/12/2015.

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53.

Zent CS, Burack WR

Hematology. 2014 December 52014 (1):119-24. Epub 11/18/2014.

Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.

Spence JM, Abumoussa A, Spence JP, Burack WR

The Journal of immunology : official journal of the American Association of Immunologists.. 2014 November 15193 (10):4888-94. Epub 10/13/2014.

A highly curable lymphoma occurs preferentially in the proximal tibia of young patients.

Subik MK, Herr MM, Hutchison RE, Kelly J, Tyler WK, Merzianu M, Burack WR

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2014 November 27 (11):1430-1437. Epub 04/18/2014.

R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433.

Friedberg JW, Unger JM, Burack WR, Gopal AK, Raju RN, Nademanee AP, Kaminski MS, Li H, Press OW, Miller TP, Fisher RI

British journal of haematology.. 2014 August 166 (3):382-9. Epub 04/18/2014.

Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas.

Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos I, Agarwal AB, Jung J, Burack R, Zhou X, Leonard EJ, Fingert H, Danaee H, Bernstein SH

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 January 132 (1):44-50. Epub 09/16/2013.

Extracellular crystals in plasma cell myeloma.

Brown JT, Burack WR, Becker MW, Vlad-Vonica R, Nadasdy T, Bennett JM, Mendler JH

Leukemia research reports.. 2014 3 (2):49-50. Epub 06/18/2014.

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213.

Bernstein SH, Epner E, Unger JM, Leblanc M, Cebula E, Burack R, Rimsza L, Miller TP, Fisher RI

Annals of oncology : official journal of the European Society for Medical Oncology. 2013 June 24 (6):1587-93. Epub 03/15/2013.

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, Liesveld J, Ryan DH, Richard Burack W, Bennett JM

Leukemia research.. 2012 January 36 (1):81-6. Epub 09/03/2011.

Relevance of IgVH gene somatic hypermutation and interphase cytogenetics in lymphomatous presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma.

Yeung CC, Powers ML, Nguyen TD, Kreisel F, Frater JL, Zehnbauer BA, Burack R, Hassan A

International journal of surgical pathology.. 2011 October 19 (5):563-9. Epub 05/01/2011.

Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation.

Hilchey SP, Rosenberg AF, Hyrien O, Secor-Socha S, Cochran MR, Brady MT, Wang JC, Sanz I, Burack WR, Quataert SA, Bernstein SH

Blood.. 2011 September 29118 (13):3591-602. Epub 08/05/2011.

Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.

Spence JM, Rothberg PG, Wang N, Burack WR

The Journal of molecular diagnostics : JMD.. 2011 May 13 (3):252-62. Epub 1900 01 01.

Combined core needle biopsy and fine-needle aspiration with ancillary studies correlate highly with traditional techniques in the diagnosis of nodal-based lymphoma.

Amador-Ortiz C, Chen L, Hassan A, Frater JL, Burack R, Nguyen TT, Kreisel F

American journal of clinical pathology.. 2011 April 135 (4):516-24. Epub 1900 01 01.

A case of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-unrelated but Epstein-Barr virus-positive primary effusion lymphoma-like lymphoma in the setting of human immunodeficiency virus and hepatitis C virus infection.

Cooper AR, Burack WR, Allerton JP

Leukemia & lymphoma.. 2010 December 51 (12):2303-5. Epub 10/07/2010.

A 48-year-old woman with a large mediastinal mass.

Ferrantino M, Eichelberger J, Burack HR, Li F, Lee FE

Chest.. 2010 November 138 (5):1260-4. Epub 1900 01 01.

Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?

Bennett JM, Pryor J, Laughlin TS, Rothberg PG, Burack WR

American journal of clinical pathology.. 2010 October 134 (4):648-52. Epub 1900 01 01.

PCR assays detect B-lymphocyte clonality in formalin-fixed, paraffin-embedded specimens of classical hodgkin lymphoma without microdissection.

Burack WR, Laughlin TS, Friedberg JW, Spence JM, Rothberg PG

American journal of clinical pathology.. 2010 July 134 (1):104-11. Epub 1900 01 01.

Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.

Hilchey SP, Kobie JJ, Cochran MR, Secor-Socha S, Wang JC, Hyrien O, Burack WR, Mosmann TR, Quataert SA, Bernstein SH

The Journal of immunology : official journal of the American Association of Immunologists.. 2009 November 15183 (10):6157-66. Epub 10/28/2009.

The incidence, natural history, biology, and treatment of transformed lymphomas.

Bernstein SH, Burack WR

Hematology. 2009 :532-41. Epub 1900 01 01.

Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction.

Vomastek T, Iwanicki MP, Burack WR, Tiwari D, Kumar D, Parsons JT, Weber MJ, Nandicoori VK

Molecular and cellular biology.. 2008 November 28 (22):6954-66. Epub 09/15/2008.

Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma.

Halldórsdóttir AM, Frühwirth M, Deutsch A, Aigelsreiter A, Beham-Schmid C, Agnarsson BA, Neumeister P, Richard Burack W

Leukemia research.. 2008 July 32 (7):1015-21. Epub 01/04/2008.

Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: superior performance of the IGK assays compared to IGH for suboptimal specimens.

Halldórsdóttir AM, Zehnbauer BA, Burack WR

Leukemia & lymphoma.. 2007 July 48 (7):1338-43. Epub 1900 01 01.

Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53.

Seo J, Chung YS, Sharma GG, Moon E, Burack WR, Pandita TK, Choi K

Oncogene.. 2005 December 824 (55):8176-86. Epub 1900 01 01.

Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.

Markiewicz MA, Carayannopoulos LN, Naidenko OV, Matsui K, Burack WR, Wise EL, Fremont DH, Allen PM, Yokoyama WM, Colonna M, Shaw AS

The Journal of immunology : official journal of the American Association of Immunologists.. 2005 September 1175 (5):2825-33. Epub 1900 01 01.

Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma.

Tu PH, Giannini C, Judkins AR, Schwalb JM, Burack R, O'Neill BP, Yachnis AT, Burger PC, Scheithauer BW, Perry A

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2005 August 2023 (24):5718-27. Epub 07/11/2005.

Live Cell Imaging of ERK and MEK: simple binding equilibrium explains the regulated nucleocytoplasmic distribution of ERK.

Burack WR, Shaw AS

The Journal of biological chemistry.. 2005 February 4280 (5):3832-7. Epub 11/16/2004.

The immunological synapse balances T cell receptor signaling and degradation.

Lee KH, Dinner AR, Tu C, Campi G, Raychaudhuri S, Varma R, Sims TN, Burack WR, Wu H, Wang J, Kanagawa O, Markiewicz M, Allen PM, Dustin ML, Chakraborty AK, Shaw AS

Science.. 2003 November 14302 (5648):1218-22. Epub 09/25/2003.

Cutting edge: quantitative imaging of raft accumulation in the immunological synapse.

Burack WR, Lee KH, Holdorf AD, Dustin ML, Shaw AS

The Journal of immunology : official journal of the American Association of Immunologists.. 2002 September 15169 (6):2837-41. Epub 1900 01 01.

Immature CD4(+)CD8(+) thymocytes form a multifocal immunological synapse with sustained tyrosine phosphorylation.

Hailman E, Burack WR, Shaw AS, Dustin ML, Allen PM

Immunity.. 2002 June 16 (6):839-48. Epub 1900 01 01.

Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.

Nguyen A, Burack WR, Stock JL, Kortum R, Chaika OV, Afkarian M, Muller WJ, Murphy KM, Morrison DK, Lewis RE, McNeish J, Shaw AS

Molecular and cellular biology.. 2002 May 22 (9):3035-45. Epub 1900 01 01.

Regulation of Lck activity by CD4 and CD28 in the immunological synapse.

Holdorf AD, Lee KH, Burack WR, Allen PM, Shaw AS

Nature immunology.. 2002 March 3 (3):259-64. Epub 02/04/2002.

The relationship between compositional phase separation and vesicle morphology: implications for the regulation of phospholipase A2 by membrane structure.

Burack WR, Dibble AR, Biltonen RL

Chemistry and physics of lipids.. 1997 November 1990 (1-2):87-95. Epub 1900 01 01.

Changes in vesicle morphology induced by lateral phase separation modulate phospholipase A2 activity.

Burack WR, Dibble AR, Allietta MM, Biltonen RL

Biochemistry.. 1997 August 2636 (34):10551-7. Epub 1900 01 01.

The activating dual phosphorylation of MAPK by MEK is nonprocessive.

Burack WR, Sturgill TW

Biochemistry.. 1997 May 2036 (20):5929-33. Epub 1900 01 01.

Modulation of phospholipase A2: identification of an inactive membrane-bound state.

Burack WR, Gadd ME, Biltonen RL

Biochemistry.. 1995 November 1434 (45):14819-28. Epub 1900 01 01.

Lipid bilayer heterogeneities and modulation of phospholipase A2 activity.

Burack WR, Biltonen RL

Chemistry and physics of lipids.. 1994 September 673 (1-2):209-22. Epub 1900 01 01.

Role of lateral phase separation in the modulation of phospholipase A2 activity.

Burack WR, Yuan Q, Biltonen RL

Biochemistry.. 1993 January 1932 (2):583-9. Epub 1900 01 01.

Expression of a group II phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus in Escherichia coli: recovery and renaturation from bacterial inclusion bodies.

Lathrop BK, Burack WR, Biltonen RL, Rule GS

Protein expression and purification.. 1992 December 3 (6):512-7. Epub 1900 01 01.

Books

Molecular Pathology of Hematolymphoid Disease (2010)

Chapter: The Roles of Molecular Techniques in the Diagnosis and Management of Follicular Lymphoma

Authors: W. Richard Burack

Publisher: Springer 2010

Translational and Experimental Clinical Research (2005)

Chapter: Non-imaging Cell and Tissue Techniques and Tissue Banking

Authors: W. Richard Burack John D. Pfeifer

Publisher: Lippincott Williams and Wilkins, Philadelphia, PA 2005

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.